World Journal of Gastroenterology 2006 Issue 23 Quantitative analysis using ELISA of vascular endothelial growth factor and basic fibroblast growth factor in human colorectal cancer, liver metastasis of colorectal cancer and hepatocellular carcinoma

Quantitative analysis using ELISA of vascular endothelial growth factor and basic fibroblast growth factor in human colorectal cancer, liver metastasis of colorectal cancer and hepatocellular carcinoma
Muriel Mathonnet;Bernard Descottes;Denis Valleix;Fran(c)ois Labrousse;Véronique Truffinet;Yves Denizot

..............page:3782-3783

Large mucinous biliary cystadenoma with "ovarian-like" stroma: A case report
Mircea Beuran;Mircea Dan Venter;Laura Dumitru

..............page:3779-3781

Management of ischemic proctitis with severe rectal haemorrhage: A case report
Vincent SK Yip;Martin Downey;Nee Beng Teo;John R Anderson

..............page:3776-3778

Purification and characterization of α-L-fucosidase from human primary hepatocarcinoma tissue
Chao Li;Jie Qian;Ju-Sheng Lin

..............page:3770-3775

Loss of heterozygosity and microsatellite instabilities of fragile histidine triad gene in gastric carcinoma
Yu-Ping Xiao;Dong-Ying Wu;Lei Xu;Yan Xin

..............page:3766-3769

Treatment of patients with advanced gastrointestinal stromal tumor of small bowel: Implications of imatinib mesylate
Chun-Nan Yeh;Tsung-Wen Chen;Ting-Jung Wu;Swei Hsueh;Yi-Yin Jan

..............page:3760-3765

Risk factors for retinopathy associated with interferon α-2b and ribavirin combination therapy in patients with chronic hepatitis C
Chiaki Okuse;Hiroshi Yotsuyanagi;Yoshihiko Nagase;Yuhtaro Kobayashi;Kiyomi Yasuda;Kazuhiko Koike;Shiro Iino;Michihiro Suzuki;Fumio Itoh

..............page:3756-3759

N-acetylcysteine does not prevent post-endoscopic retrograde cholangiopancreatography hyperamylasemia and acute pancreatitis
Janusz Milewski;Grazyna Rydzewska;Malgorzata Degowska;Maciej Kierzkiewicz;Andrzej Rydzewski

..............page:3751-3755

Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus
Ines Gockel;Kathrin Dirksen;Claudia M Messow;Theodor Junginger

..............page:3746-3750

Immunohistochemical expression of mismatch repair genes: A screening tool for predicting mutator phenotype in liver fluke infection-associated intrahepatic cholangiocarcinoma
Upama Liengswangwong;Anant Karalak;Yukio Morishita;Masayuki Noguchi;Thiravud Khuhaprema;Petcharin Srivatanakul;Masanao Miwa

..............page:3740-3745

Activation and dramatically increased cytolytic activity of tumor specific T lymphocytes after radio-frequency ablation in patients with hepatocellular carcinoma and colorectal liver metastases
Johannes H(a)nsler;Thadd(a)us Till Wissniowski;Detlef Schuppan;Astrid Witte;Thomas Bernatik;Eckhart Georg Hahn;Deike Strobel

..............page:3716-3721

Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma
Arne Dettmer;Timm D Kirchhoff;Michael Gebel;Lars Zender;Nisar P Malek;Bernhard Panning;Ajay Chavan;Herbert Rosenthal;Stefan Kubicka;Susanne Krusche;Sonja Merkesdal;Michael Galanski;Michael P Manns;Joerg S Bleck

..............page:3707-3715

Platelet-activating factor in liver injury: A relational scope
Nikolaos P Karidis;Gregory Kouraklis;Stamatios E Theocharis

..............page:3695-3706

Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy
Giada Sebastiani;Alfredo Alberti

..............page:3682-3694

OCTNs: Will the real IBD5 gene please stand up?
Mark S Silverberg

..............page:3678-3681

NOD2: Ethnic and geographic differences
Juleen Cavanaugh

..............page:3673-3677

Autoimmune liver disease and the Canadian First Nations Aboriginal Communities of British Columbia's Pacific Northwest
Eric M Yoshida;Mark Riley;Laura T Arbour

..............page:3625-3627

Family and twin studies in inflammatory bowel disease
Leena Halme;Paulina Paavola-Sakki;Ulla Turunen;Maarit Lappalainen;Martti F(a)rkkil(a);Kimmo Kontula

..............page:3668-3672

Pharmacogenetics in inflammatory bowel disease
Marie Pierik;Paul Rutgeerts;Robert Vlietinck;Severine Vermeire

..............page:3657-3667

Role of discs large homolog 5
Frauke Friedrichs;Monika Stoll

..............page:3651-3656

Immunogenetic phenotypes in inflammatory bowel disease
Marla C Dubinsky;Kent Taylor;Stephan R Targan;Jerome I Rotter

..............page:3645-3650

Multidrug resistance 1 gene in inflammatory bowel disease: A meta-analysis
V Annese;MR Valvano;O Palmieri;A Latiano;F Bossa;A Andriulli

..............page:3636-3644

Genetics of inflammatory bowel disease: The role of the HLA complex
Tariq Ahmad;Sara E Marshall;Derek Jewell

..............page:3628-3635

Sclerosing cholecystitis associated with autoimmune pancreatitis
Terumi Kamisawa;Yuyang Tu;Hitoshi Nakajima;Naoto Egawa;Kouji Tsuruta;Atsutake Okamoto;Shinichirou Horiguchi

..............page:3736-3739

Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-κB activation
Christian U Riedel;Francis Foata;David Philippe;Oskar Adolfsson;Bernhard J Eikmanns;Stephanie Blum

..............page:3729-3735

Mutations in carboxy-terminal part of E2 including PKR/eIF2αphosphorylation homology domain and interferon sensitivity determining region of nonstructural 5A of hepatitis C virus 1b:Their correlation with response to interferon monotherapy and viral load
Koji Ukai;Masatoshi Ishigami;Kentaro Yoshioka;Naoto Kawabe;Yoshiaki Katano;Kazuhiko Hayashi;Takashi Honda;Motoyoshi Yano;Hidemi Goto

..............page:3722-3728